Internal Medicine, Infectious Disease · Provo, UT
NPI
1063575199
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
395 W Cougar Blvd Ste 202
Provo, UT, 84604
Phone (801) 357-1772
Groups this clinician bills Medicare through
Medicare paid, 2024
$715K
48,177 services
Medicare patients, 2024
485
Average age 70
Drug cost, 2024
$1.0M
1,962 prescriptions
Company payments, 2025
$86K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cedric W Spak was code J0485 (injection, belatacept, 1 mg), 14,128 times for 19 patients. In total Cedric W Spak billed 48,177 services in 53 codes, and Medicare paid $715K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0485 Injection, belatacept, 1 mg | Office | 14,128 | 19 | $2.99 | $42K |
| 99232 Hospital E&M - Subsequent | Facility | 846 | 194 | $66.03 | $56K |
| 99233 Hospital E&M - Subsequent | Facility | 732 | 131 | $98.71 | $72K |
| 96365 Intravenous Infusion, Hydration | Office | 392 | 65 | $52.84 | $21K |
| 99214 Office E&M - Established | Office | 360 | 202 | $107.69 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 342 | 206 | $13.78 | $4,712 |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 293 | 16 | $9.13 | $2,676 |
| 99223 Hospital E&M - Initial | Facility | 175 | 156 | $145.41 | $25K |
| 96366 Intravenous Infusion, Hydration | Office | 156 | 11 | $17.19 | $2,682 |
| 99222 Hospital E&M - Initial | Facility | 116 | 102 | $109.56 | $13K |
| 36592 Vascular | Office | 70 | 23 | $23.69 | $1,658 |
| 99204 Office E&M - New | Office | 47 | 47 | $138.71 | $6,519 |
| 99231 Hospital E&M - Subsequent | Facility | 32 | 11 | $41.57 | $1,330 |
| 99213 Office E&M - Established | Office | 29 | 29 | $77.45 | $2,246 |
| 36573 Venous Catheter Insertion | Office | 28 | 25 | $311.86 | $8,732 |
By year: 2022 $1.0M for 122,636 services; 2023 $813K for 109,002 services; 2024 $715K for 48,177 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cedric W Spak prescribed most often to Medicare patients was Daptomycin, with 235 prescriptions and refills. In total Cedric W Spak wrote 1,962 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 235 | 235 | 48 | $109K |
| Meropenem Generic | 212 | 212 | 28 | $36K |
| Cefepime Hcl Generic | 189 | 189 | 52 | $41K |
| Ertapenem Ertapenem Sodium | 149 | 149 | 35 | $71K |
| Vancomycin Hcl Generic | 123 | 128 | 38 | $23K |
| Minocycline Hcl Generic | 110 | 229 | 60 | $5,245 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 76 | 76 | Under 11 | $319K |
| Ceftriaxone Ceftriaxone Sodium | 55 | 55 | 17 | $4,267 |
| Sodium Chloride 0.9 % Sodium Chloride | 53 | 53 | Under 11 | $840 |
| Ciprofloxacin Hcl Generic | 50 | 86 | 28 | $1,069 |
| Cephalexin Generic | 45 | 104 | 20 | $1,466 |
| Amoxicillin Generic | 42 | 96 | 18 | $583 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 38 | 64 | 21 | $1,217 |
| Doxycycline Monohydrate Generic | 36 | 63 | 15 | $1,484 |
| Micafungin Micafungin Sodium | 35 | 35 | Under 11 | $17K |
Brand drugs: - claims; generic drugs: 1,648 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cedric W Spak $86K ($86K in general payments such as food, travel and fees) from 11 companies. The largest payer was Shionogi Inc with $26K.
| Company | Payments | Amount |
|---|---|---|
| Shionogi Inc 4507.T | 35 | $26K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 34 | $24K |
| Abbvie Inc. ABBV | 27 | $15K |
| Invivyd Inc IVVD | 11 | $9,647 |
| La Jolla Pharmaceutical Company | 10 | $8,299 |
| Pfizer Inc. PFE | 3 | $1,824 |
| Insmed, Inc. INSM | 14 | $270 |
| Ferring Pharmaceuticals Inc. | 2 | $147 |
| ViiV Healthcare Company GSK | 1 | $30.6 |
| Aimmune Therapeutics, Inc. | 1 | $29.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.